Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company has zero debt and is sitting a huge pile of billions of cash. It has a strong pipeline with products in late stage$$$$
Moderna had completed their $1B stock buyback program in January. This is nice because it speaks to their confidence in the value of their own stock. They have another $3B on standby by for the next purchase.
If you listen to the Yahoo Finance interview with CEO Stephane Bancel, he says that of the $19 billion in secured government contracts and $3 billion in options for 2022 COVID-19 vaccines, literally none of that money is from the United States. If the United States contracts with Moderna to purchase more vaccine doses in 2022, that $19 billion + $3 billion in options already secured for 2022 could go up to $25-30 billion+
https://finance.yahoo.com/video/covid-19-vaccine-global-oversupply-164738047.html
50B market cap and it has 17B in cash... so net 33B for a company with locked in 2022 revenue of 19B.
cheapest stock there is.......
Commercial Outlook in 2023 & Beyond
Spikevax ® 2023 commercial outlook: Moderna has received firm orders for delivery in 2023 from the United Kingdom, Canada, Taiwan, and Kuwait. The Company is currently in active discussions for additional orders in 2023.
Supply agreements with strategic countries: Moderna is committed to expanding its partnerships with governments to equip countries with access to innovative vaccines against respiratory viruses, and domestic access to rapid pandemic response capabilities. To date, Moderna has announced in principle agreements with Australia and Canada and the Company is in discussions with additional countries for similar partnerships.
EMA recommends approval of Spikevax for children aged 6 to 11
https://www.ema.europa.eu/en/news/ema-recommends-approval-spikevax-children-aged-6-11
Moderna Beats Earnings Estimates$$$$$$$$$$ relax
Q4 2021 revenues of $7.2 billion; GAAP net-income of $4.9 billion and GAAP diluted EPS of $11.29
Full year 2021 revenues of $18.5 billion; GAAP net-income of $12.2 billion and GAAP diluted EPS of $28.29
Moderna increased its 2022 signed advance purchase agreements to approximately $19 billion, with additional signed options of approximately $3 billion; numerous discussions ongoing with governments for the fall of 2022 and 2023
Moderna received full U.S. FDA approval for COVID-19 vaccine, Spikevax
Moderna announces new bivalent booster candidate (mRNA-1273.214) combining Omicron-specific booster candidate (mRNA-1273.529) and the Moderna COVID-19 vaccine (mRNA-1273)
Company now has 44 programs in development
Moderna announces a new $3 billion share repurchase plan
$MRNA
https://investors.modernatx.com/news/news-details/2022/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2021-Financial-Results-and-Provides-Business-Updates/default.aspx
Moderna, the biotech company focused on drug discovery, is expected to report its fourth-quarter earnings of $8.62 per share, which represents year-over-year growth of over 1,340% from a loss of -$0.69 per share seen in the same period a year ago.
The Massachusetts-based biotechnology company would post revenue growth of 1,075% to around $6.71 billion up from $570.75 million a year earlier.
According to ZACKS Research, the company forecasts sales of $17.5 billion in 2021. It also has advance purchase agreements worth nearly $20 billion for 2022 for the vaccine.
BIG news out: Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax®, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline.
Thermo Fisher will now provide dedicated capacity for a range of aseptic fill-finish services including lyophilized and liquid filling. In addition, the company will provide inspection, labeling and final packaging services.
Moderna’s innovation in mRNA technology has been pivotal in the global response to the pandemic and we are proud and privileged to support Moderna over the last decade,” said Michel Lagarde, executive vice president and chief operating officer of Thermo Fisher Scientific. “In expanding our strategic partnership, Moderna will further leverage our scale and depth of capabilities to continue to transform its mRNA platform and bring new breakthrough medicines to patients around the world."
https://www.businesswire.com/news/home/20220222006242/en/
MODERNA TO REPORT FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS ON THURSDAY, FEBRUARY 24, 2022
let's see what happens!!!!!!!
LOL Don't talk shit. Hong Kong: What went wrong with its Covid plan? Just outside the hospital's emergency room, dozens of hospital beds had been placed in an alley under makeshift tents. The air was punctuated by the moans of patients - most of whom were elderly - and cries of children. All were suspected or confirmed Covid cases waiting to be admitted.
https://www.bbc.com/news/world-asia-china-60474342
BIG COMPANY: Moderna has a commercial presence in 11 countries worldwide (Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, Switzerland, UK, U.S.) and recently announced plans to increase its commercial footprint across ten additional markets in Asia-Pacific (Hong Kong, Malaysia, Singapore, Taiwan) and Europe (Belgium, Denmark, the Netherlands, Norway, Poland, Sweden) in 2022.
The Company also has commercial agreements with distributors to supply the Company's COVID-19 vaccine in 45 countries, with Zuellig Pharma in the Asia Pacific, Medison Pharma in Central Eastern Europe and Israel, and Adium Pharma in Latin America. In addition, Moderna announced an agreement with Gavi, the Vaccine Alliance, to supply up to 650 million doses of the Company's COVID-19 Vaccine across 2021 and 2022, covering the 92 Gavi COVAX Advance Market Commitment (AMC) low- and middle-income countries.
Regulators have approved Moderna's COVID-19 vaccine in more than 70 markets, including Canada, Japan, the European Union, the UK, and Israel. In 2021, 807 million doses of Moderna's COVID-19 vaccine were shipped globally, with approximately 25% of those doses shipped to low- and middle-income markets. In Latin America, Moderna has established bilateral and supranational supply agreements in 15 countries.
anyone that honestly thinks COVID is done is a complete idiot!
MODERNA ESPANDE L'IMPRONTA GLOBALE ATTRAVERSO UNA PARTNERSHIP COMMERCIALE CON ADIUM IN AMERICA LATINA
The agreement covers 18 countries in Latin America, including Brazil, Mexico, Colombia, and Argentina.
https://investors.modernatx.com/news/news-details/2022/Moderna-Expands-Global-Footprint-Through-Commercial-Partnership-with-Adium-in-Latin-America/default.aspx
two vaccines, in phase 3 CMV RSV big company!
news out: MODERNA INITIATES PHASE 3 PORTION OF PIVOTAL TRIAL FOR MRNA RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE, FOLLOWING INDEPENDENT SAFETY REVIEW OF INTERIM DATA
The DSMB’s endorsement comes after independent review of preliminary Phase 2 data, which suggest that the vaccine has an acceptable safety profile in older adults at the selected dose. We expect to enroll approximately 34,000 participants in multiple countries.
https://investors.modernatx.com/news/news-details/2022/Moderna-Initiates-Phase-3-Portion-of-Pivotal-Trial-for-mRNA-Respiratory-Syncytial-Virus-RSV-Vaccine-Candidate-Following-Independent-Safety-Review-of-Interim-Data/default.aspx
Study from Japan shows that Omicron BA2 (known 1s stealth omicron) may be as severe as Delta, and 30pc more contagious than omicron... if this is confirmed true, we will need additional vaccine by next summer to avoid new waves and restrictions...
https://edition.cnn.com/2022/02/17/health/ba-2-covid-severity/index.html
1 Crucial Thing to Look For in Moderna's Earnings Report:
https://www.fool.com/investing/2022/02/19/1-crucial-thing-to-look-for-in-modernas-earnings-r/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
Speaking at Germany’s annual Munich Security Conference on Friday, globalist billionaire Bill Gates confidently warned the world a new pandemic is coming.
Gates’ solution to the dilemma of prioritizing vaccinations is to have the capability to produce 2 doses of a vaccine for every person on the planet.
https://nworeport.me/2022/02/19/bill-gates-well-have-another-pandemic-it-will-be-a-different-pathogen-next-time/
Moderna unveiled efforts to develop vaccines for herpes, shingles, and cancer on Friday as it continues to put the enormous cash reserves it has earned through sales of its Covid-19 vaccine to work in expanding its pipeline of products.
The CEO Is Looking Beyond Covid......
There may some good announcements MRNA on 24th Feb!
new: Our checkpoint cancer vaccine candidate (mRNA-4359) expresses Indoleamine 2,3-dioxygenase and programmed death-ligand 1 antigens, and was designed with the goal of stimulating effector T-cells that target and kill suppressive immune and tumor cells that express target antigens.
The 5 Technologies That Will Change The Future Of The Human Race
Artificial Intelligence: https://bernardmarr.com/the-5-technologies-that-will-change-the-future-of-the-human-race/
Second: The Company is in discussions with two companies for a potential merger or acquisition. One is an online software company that provides law firms, debt buyers, collection agencies and other small businesses with state-of-the-art platforms and technology to manage their operations. The other is an artificial intelligence service.
artificial intelligence,,,,is the future!
AI is going to revolutionize almost every facet of modern life!
news out: MODERNA EXPANDS ITS MRNA PIPELINE WITH THREE NEW DEVELOPMENT PROGRAMS
FEBRUARY 18, 2022
mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV)
mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles)
mRNA-4359 is a new checkpoint cancer vaccine
https://investors.modernatx.com/news/news-details/2022/Moderna-Expands-Its-mRNA-Pipeline-with-Three-New-Development-Programs/default.aspx
mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants
https://www.nature.com/articles/s41598-022-06629-2
$MRNA winner
The 5 Technologies That Will Change The Future Of The Human Race
Artificial Intelligence: https://bernardmarr.com/the-5-technologies-that-will-change-the-future-of-the-human-race/
Second: The Company is in discussions with two companies for a potential merger or acquisition. One is an online software company that provides law firms, debt buyers, collection agencies and other small businesses with state-of-the-art platforms and technology to manage their operations. The other is an artificial intelligence service.
artificial intelligence,,,,is the future!
AI is going to revolutionize almost every facet of modern life!
We are pleased to announce plans to expand our footprint in Europe with a commercial presence in Belgium, Denmark, Norway, the Netherlands, Poland, and Sweden. This follows our recent announcement of plans for four new subsidiaries in Asia-Pacific.
https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Plan-to-Expand-Commercial-Footprint-in-Europe-Across-Six-Additional-Countries/default.aspx
Denmark warning US, Covid skyrocketing after lifting restrictions,
Topol’s argument was clear: By ending mitigation measures prematurely, Denmark has brought a resurgence of infection, hospitalization and death upon itself — and anyone who follows in the country’s footsteps risks doing the same.
THERAPEUTIC GOODS ADMINISTRATION OF AUSTRALIA AUTHORIZES MODERNA'S COVID-19 VACCINE IN CHILDREN (6-11 YEARS)
https://investors.modernatx.com/news/news-details/2022/Therapeutic-Goods-Administration-of-Australia-Authorizes-Modernas-Covid-19-Vaccine-in-Children-6-11-Years/default.aspx
HI what should happen?
Moderna CEO says it's working to get its Covid vaccine authorized in Hong Kong:
Hospitalizations of kids under 5 rose fivefold with omicron:
https://www.mercurynews.com/2022/02/15/omicron-drove-up-kids-covid-19-hospitalization-rates-by-how-much-now-the-cdc-knows/
Virological characteristics of SARS-CoV-2 BA.2 variant
https://www.biorxiv.org/content/10.1101/2022.02.14.480335v1
Why It's Time to Buy Moderna Stock Again
https://www.fool.com/investing/2022/02/16/why-its-time-to-buy-moderna-stock-again/
Moderna CEO says it’s ‘reasonable’ to think the pandemic may be in its final stages
https://www.cnbc.com/2022/02/16/moderna-ceo-says-its-reasonable-to-think-pandemic-may-be-in-its-final-stages.html
Moderna and ROVI Expand Long-term Collaboration for the Manufacture of MRNA Medicines Over the Next Ten Years
https://www.reuters.com/business/healthcare-pharmaceuticals/rovi-seals-10-year-moderna-deal-extension-manufacture-mrna-drugs-2022-02-16/
the work continues$$$$$$$$
Latest Disclosed Ownership 31,538,184 shares!!!!!!!!!
https://fintel.io/so/us/mrna/bancel-stephane
https://xcelrev.com/business/ a good candidate!
Babies are protected from hospitalization for Covid if their moms get vaccinated,
The CDC found infants less than 6 months old were 61% less likely to be hospitalized with Covid if their mothers received Pfizer or Moderna’s vaccine during pregnancy.
https://www.cnbc.com/2022/02/15/babies-are-protected-from-hospitalization-for-covid-if-their-moms-get-vaccinated-study-suggests.html
Moderna continues to expand its commercial footprint so be as to support markets around the world in deploying vaccines which have the potential to provide “health security” against vaccine preventable diseases!
MODERNA ANNOUNCES PLAN TO EXPAND FOOTPRINT IN ASIA WITH FOUR ADDITIONAL SUBSIDIARIES
https://investors.modernatx.com/news/news-details/2022/Moderna-Announces-Plan-to-Expand-Footprint-in-Asia-with-Four-Additional-Subsidiaries/default.aspx
we await confirmation$$$$$$